Physician

Steven Montana, D.O.

According to 2025 Medicare claims, Steven Montana, D.O. (NPI: 1225034788) practices hematology/oncology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Suffolk, NY. This provider's primary affiliated billing organization is NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (NPI: 1396794574; TIN: 112419534) and primary practice location at 11787-0001. Montana is affiliated with the ilumed, LLC (ACO ID: D0005) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Montana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,512 traditional Medicare patients, billed 325,937 HCPCS/CPT codes, and received $4,500,704 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,303 prescription claims across 272 beneficiaries totaling $8,554,058 in drug costs, led by Revlimid (Lenalidomide). DME data shows 11 claims. Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $819,880 to $4,500,704. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,021,317 to $8,554,058. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	880	52,808	$819,880
2016	1,332	81,996	$1,127,542
2017	1,477	156,256	$1,792,428
2018	1,562	269,358	$3,345,817
2019	2,139	346,995	$5,375,815
2020	1,738	241,325	$3,803,001
2021	1,685	270,689	$4,132,295
2022	1,797	255,014	$3,378,857
2023	2,588	302,294	$3,854,690
2024	2,512	325,937	$4,500,704

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	118	600	$1,021,317
2016	143	890	$2,026,106
2017	164	955	$2,448,895
2018	171	1,102	$3,106,583
2019	193	1,156	$2,784,147
2020	195	1,380	$2,871,332
2021	213	1,395	$3,330,623
2022	224	1,549	$4,574,168
2023	241	1,727	$6,127,046
2024	272	2,303	$8,554,058

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$1,106
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	22	48	$7,302
2019	50	104	$12,300
2020	39	52	$4,327
2021	N/R	79	$4,865
2022	N/R	92	$2,487
2023	N/R	N/R	N/R
2024	N/R	11	$447

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,162	2,605	$108
80053	Blood test, comprehensive group of blood chemicals	1,636	3,577	$10
36415	Insertion of needle into vein for collection of blood sample	1,884	4,786	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,807	4,727	$8
83615	Lactate dehydrogenase (enzyme) level	1,281	2,847	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	55	1,463	$790,709
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	87	2,324	$553,126
Darzalex Faspro	Daratumumab-Hyaluronidase-Fihj	49	1,396	$527,646
Aranesp	Darbepoetin Alfa In Polysorbat	174	3,844	$413,042
Jakafi	Ruxolitinib Phosphate	25	750	$410,143

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	11	$447

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$15	Tempus AI, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Steven Montana, D.O.?

Tedicare shows public-source Medicare data for Steven Montana, D.O. (NPI 1225034788), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven Montana, D.O. have ACO affiliation data?

Steven Montana, D.O. is shown with ACO affiliation data for ilumed, LLC (REACH, ACO ID D0005) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Steven Montana, D.O.?

Steven Montana, D.O. is linked to NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (billing NPI 1396794574) in the available physician profile data.

Does Steven Montana, D.O. have Open Payments data?

Steven Montana, D.O. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.